Information Provided By:
Fly News Breaks for September 19, 2017
TEVA
Sep 19, 2017 | 08:38 EDT
Wells Fargo analyst David Maris notes that Teva announced that it has entered into two separate agreements to sell the remaining assets in its specialty global women's health business for an aggregate of $1.38B. While the sale is a step in the right direction for Teva, the analyst notes that the proceeds amount to only small step toward lowering Teva's approximate $35B in debt. He reiterates a Market Perform rating on the shares.